Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Recurrence 4Leukemia, Myeloid, Acute 3Leukemia, Biphenotypic, Acute 3Prostatic Neoplasms 2Myelodysplastic Syndromes 2Lymphoma, T-Cell 2Leukemia 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasm Metastasis 1Lymphoma, T-Cell, Peripheral 1Lymphoma, B-Cell 1Leukemia, T-Cell 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Lymphoid 1Hodgkin Disease 1Hematologic Neoplasms 1Blastic Plasmacytoid Dendritic Cell Neoplasm 1

Interventions

fludarabine 3venetoclax 2tagraxofusp 2fludarabine phosphate 2Dexamethasone 2Cytarabine 2Cyclophosphamide 2Calcium Dobesilate 2Azacitidine 2dexamethasone acetate 1dexamethasone 21-phosphate 1auricularum 1Vincristine 1Specimen Handling 1Rituximab 1Ranitidine 1Methotrexate 1Mesna 1Magnetic Resonance Spectroscopy 1MK 2206 1Ibuprofen 1Hydrocortisone 1Diphenhydramine 1Biopsy 1Acetaminophen 1AP 1903 reagent 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Blastic Plasmacytoid Dendritic Cell Neoplasm × Hydrocortisone × Clear all
NCT05476770 2024-12-06

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Therapeutic Advances in Childhood Leukemia Consortium

Phase 1 Recruiting
54 enrolled
LymphoidMyeloidOther hematologic neoplasm

Blastic Plasmacytoid Dendritic Cell Neoplasm, Hodgkin Disease, Leukemia, Biphenotypic, Acute, Lymphoma, B-Cell, Lymphoma, T-Cell, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡